<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for BDSI</title>
    <link />
    <description>Headlines for BIODELIVERY SCIENCES INTERNATIONAL, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>BioDelivery Sciences Submits NDA for BUNAVAIL</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3660732/biodelivery-sciences-submits-nda-for-bunavail.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 10 Jun 2013 07:02:14 GMT</pubDate>
    </item>
    <item>
      <title>BioDelivery Sciences Primed To Grab Its Share Of The $1.5B Opioid Market</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/bdsi/articles/188906/biodelivery-sciences-primed-to-grab-its-share-of-the-1-5b-opioid-market/2013-05-28.aspx</link>
      <author>Trefis</author>
      <pubDate>Tue, 28 May 2013 14:23:52 GMT</pubDate>
    </item>
    <item>
      <title>BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1463171-biodelivery-sciences-primed-to-grab-its-share-of-the-1-5-billion-opioid-market.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 28 May 2013 07:57:00 GMT</pubDate>
    </item>
    <item>
      <title>BDSI Makes Notable Cross Below Critical Moving Average</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926891/1/bdsi-makes-notable-cross-below-critical-moving-average.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 17 May 2013 11:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1388931-hedge-funds-are-buying-these-3-biotech-small-caps-trading-below-lowest-target-price.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 10:12:39 GMT</pubDate>
    </item>
    <item>
      <title>2 Biotech Stocks Under $10 to Watch</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/2-biotech-stocks-under-10-watch.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 11 Apr 2013 14:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Should You Buy Reckitt Benckiser Today?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/10/should-you-buy-reckitt-benckiser-today/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 10 Apr 2013 20:32:00 GMT</pubDate>
    </item>
    <item>
      <title>BioDelivery On Track For Mid-Year NDA Filing</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1331961-biodelivery-on-track-for-mid-year-nda-filing.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 10 Apr 2013 08:26:25 GMT</pubDate>
    </item>
    <item>
      <title>3 Companies Aiming For The $1.2B Opioid Addiction Market</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1325611-3-companies-aiming-for-the-1-2b-opioid-addiction-market.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 07 Apr 2013 17:24:12 GMT</pubDate>
    </item>
    <item>
      <title>BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3446370/biodelivery-sciences-expands-product-pipeline-with-acquisition-of-patented-topica.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 26 Mar 2013 08:09:02 GMT</pubDate>
    </item>
    <item>
      <title>FDA Action Date for AMAG Drug - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94498/fda-action-date-for-amag-drug.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 18:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Stock Upgrades: Citigroup Paints the Town Red</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/stock-upgrades253a-citigroup-paints-the-town/3/11/2013/id/48636.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 11 Mar 2013 09:21:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Upgrades BioDelivery Sciences International to Overweight on Checks</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3403584/update-piper-jaffray-upgrades-biodelivery-sciences-inter.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 11 Mar 2013 07:52:32 GMT</pubDate>
    </item>
    <item>
      <title>Infinity Reports Wider Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94307/infinity-reports-wider-loss.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 08 Mar 2013 09:00:01 GMT</pubDate>
    </item>
    <item>
      <title>BioDelivery Sciences International's CEO Hosts R&amp;amp;D Day Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1258351-biodelivery-sciences-international-s-ceo-hosts-r-amp-d-day-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 08 Mar 2013 02:10:18 GMT</pubDate>
    </item>
    <item>
      <title>AMAG Narrows Loss, Maintains View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93921/amag-narrows-loss-maintains-view.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 04 Mar 2013 13:39:01 GMT</pubDate>
    </item>
    <item>
      <title>4Q Beat for The Medicines Co. - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93305/4q-beat-for-the-medicines-co.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 22 Feb 2013 14:19:01 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging News at Chelsea - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93222/encouraging-news-at-chelsea.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 21 Feb 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>3 Highly Shorted Stocks Under $5 Being Bought By Hedge Funds</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11829968/1/3-highly-shorted-stocks-under-5-being-bought-by-hedge-funds.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 01 Feb 2013 13:22:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Piper Jaffray Initiates Coverage on BioDelivery Sciences International with Neutral Rating,</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/01/3215530/update-piper-jaffray-initiates-coverage-on-biodelivery-s.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 04 Jan 2013 10:07:17 GMT</pubDate>
    </item>
  </channel>
</rss>
